Form 4: ChronoScale Corp: Director Andrew Schaap Acquires Shares

ChronoScale Corp director Andrew Schaap acquired 200,000 restricted shares of common stock on June 29, 2026, as part of a grant with a two-year vesting schedule.

Summary

• Andrew Cordell Schaap, a Director at ChronoScale Corp, acquired 200,000 restricted shares of common stock on June 29, 2026.
• The acquisition was made through a grant with no purchase price indicated.
• These shares are subject to a vesting schedule: 100,000 shares vest on the one-year anniversary of the grant date, and the remaining 100,000 shares vest on the two-year anniversary.
• Vesting is contingent upon Schaap's continuous service with the company and may be subject to adjustment or accelerated vesting under certain conditions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard equity grant to a director rather than a significant financial event or performance indicator.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The grant of 200,000 restricted shares indicates a significant equity award to a key executive.

Negatives

• The shares are restricted and subject to vesting, meaning immediate full ownership is not granted.
• The filing does not specify the performance conditions or metrics tied to the accelerated vesting clause.

Risks

• The vesting of shares is contingent on the Reporting Person's continuous service, meaning departure from the company before vesting dates would result in forfeiture.
• Potential for adjustment or accelerated vesting upon certain conditions introduces uncertainty regarding the exact timing and amount of fully vested shares.

Future Outlook

The future outlook for the acquired shares depends on the continuous service of Andrew Schaap and the company's performance, which may trigger accelerated vesting under certain conditions.

Industry Context

StockSavvy.ai notes that insider grants of restricted stock are common compensation tools for directors and executives, aligning their interests with long-term shareholder value. The specific vesting schedule and conditions are typical for such awards.

Stakeholder Impact

• Shareholders: The grant of shares to a director can be seen as a positive alignment of interests, but the dilutive effect of new shares should be considered if the company has a small float.
• Employees: This transaction does not directly impact other employees but reflects the company's compensation strategy for its board.
• Management: Andrew Schaap's compensation is directly affected by this grant and its vesting schedule.

Next Steps

• Andrew Schaap must maintain continuous service with ChronoScale Corp through the vesting dates.
• The company may adjust or accelerate vesting under specific, undisclosed conditions.

Key Dates

Keywords

ChronoScale Corp, CHRN, Form 4, Insider Trading, Stock Grant, Restricted Stock, Director Compensation, Beneficial Ownership, SEC Filing